Gilles Avenard, MD, is Chief Executive Officer at Acticor Biotech, Paris, France, and Board member or adviser for several companies through GABC, a Strategic Advisory Firm for Biotech and Pharma Industry. From 1997 to 2010, he served as Chief Operating Officer of BioAlliance Pharma – ONXEO SA (BIO – NYSE-EURONEXT) since he co-founded the company. From 1990 to 1997, Dr. Avenard served as Medical Director of Development in the Cassenne Laboratories division of Hoechst Marion Roussel (Sanofi-Aventis Pharma). From 1976 to 1990, Dr. Avenard held various positions with the National Blood Transfusion Center in Paris, including Medical Director of Bio-Transfusion (LFB), providing human plasma products. He has also served as a physician in hemobiology and blood transfusion at the Blood Center of Pitié-Salpétrière Hospital in Paris. Dr. Avenard received his M.D. as well as degrees in Hematology, Hemobiology & Blood Transfusion from the School of Medicine at the University of Paris V.